Novartis - Wikipedia
Novartis unit Sandoz starts trading at 24 Swiss francs after completing spinoff
Novartis May Turn Sandoz into Separate Entity Amidst Restructuring | BioSpace
Novartis' Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide - Xtalks
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UQPIK3T2DVOX7EIO4QZCM5HIAA.jpg "Novartis' Sandoz wagers its standalone future on biosimilar success | Reuters")
Novartis' Sandoz wagers its standalone future on biosimilar success | Reuters
Novartis' Sandoz aims for 5 biosim launches by 2020 | Fierce Pharma
Novartis says operating profit to grow again ahead of Sandoz spin off
Novartis segregará Sandoz en 2023 para crear el mayor laboratorio de genéricos | Empresas | Cinco Días
Novartis Dumps 300 Sandoz Assets for $1 Billion to Aurobindo | BioSpace
Swiss pharma's big bet on Slovenia - SWI swissinfo.ch
Analysis-Novartis CEO may struggle to rally investors to Sandoz spin-off
Novartis AG To Spin-Off Sandoz Business In 4Q23
Blackstone, Carlyle Mull Joint Bid for Novartis Generics Arm - Bloomberg
Novartis weighs sale of ophthalmology, respiratory units, Health News, ET HealthWorld
Novartis and Sandoz withdraw medicines from US over packaging concerns - Pharmaceutical Technology
Novartis May Have Sandoz Buyer on the Hook | CHEManager
A history of Novartis | pharmaphorum
Novartis To Spinoff Sandoz Business To Create #1 European Generics Company
No news anytime soon on Sandoz sale, says Novartis | pharmaphorum
Novartis to list its subsidiary Sandoz on the stock exchange - BioAlps
Novartis inches closer to selling generic drug unit, Sandoz for US$21 billion: Report | HealthCare Middle East & Africa Magazine
Sandoz acquires UK-based drug delivery device firm Coalesce | HealthCare Middle East & Africa Magazine
Novartis Will Spin Off Sandoz Generic-Drugs Unit by Next Year - BNN Bloomberg
Sandoz launches rival version of AbbVie's arthritis drug Humira
